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Table 1: Results from the Swedish TAVI registry 2008-2011
CoreValve Sapien
TAVI Sweden
2008-2011 n313 n252
Access site Transfemoral Transsubclavian Transfemoral Transapical
n 291 n22 n93 n159
Euroscore log 23.5 25.0
Device
Success %
97.8 95.8
All cause
mortality 30-
days %
5.5 7.5
All cause
mortality 1-
year %
13.3 17.0
Myocardial
infarction %
1.0 1.3
Acute Kidney
injury (2011
only) %
6.0 2.5
Life-
threatening
bleeding %
5.1 12.1
Major
vascular
bleeding %
10.2 6.4
Major stroke
%
2.1 1.9
New
permanent
pacemaker %
16.4 5.7
Fluoroscopy
time mean
minutes
29,2 22,0
Contrast
media mean
ml
177,5 134,0
Length of
Hospital stay
days
7,3 9,8
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Background: To compare the incidence and clinical significance of new bundle branch
block in patients undergoing transcatheter aortic valve implantation (TAVI) with the
Medtronic CoreValve and Edwards-Sapien prosthesis.
Methods: We analyzed data from 336 patients (pts) with no prior pacemaker who
underwent TAVI with CoreValve (n130) or Edwards (n206) prosthesis between 2007
and 2011 in our centre. We examined the 12-lead ECGs and documented the conduction
disturbances after TAVI and before discharge as compared to baseline.
Results: Mean age was similar in CoreValve (79.47.3 years) vs. Edwards group
(79.78.1 years, p0.43). New onset of left bundle branch block (LBBB) was
documented in 65 (19.3%) pts: 21 (32.2%) in Edwards vs. 44 (67.7%) in CoreValve pts
(p0.001). Of them 18 (27.7%) pts showed also a 1st atrioventricular block (AVB): 3 in
Edwards and 16 in CoreValve pts (p0.001). Permanent Pacemaker implantation (PPM)
was required in 9 (13.8%) pts because of 3rd AVB (Edwards n3; CoreValve n4),
LBBB and 1st AVB (CoreValve n1) and LBBB with sinus bradycardia (CoreValve
n1). In 14 (21.5%) pts, LBBB was temporary (5 pts, 23.8% Edwards vs. 9pts, 20.4%
CoreValve), whereas LBBB persisted in 61.9% of Edwards and in 65.9% of CoreValve
pts (p0.5) at discharge. On multivariable analysis, the predictors of LBBB were:
CoreValve prosthesis (OR:5.3 95%-CI:2.9-9.8, p0.001), and previous CABG (OR:1.9,
95%-CI:0.9-4, p0.064). New onset of LBBB was not a predictor of overall (log rank
p0.56) and cardiovascular mortality (log rank p0.61). A new onset of right bundle
branch block (RBBB) was documented in 12 (3.6%) pts (6 both in Edwards and in
CoreValve pts): 1.5% with left anterior hemiblock (LAH), 0.3% with 1st AVB and 0,6%
with both LAH and 1st AVB. There were no statistically significant differences between
Edwards and CoreValve prosthesis. 9 pts developed a new isolated 1st AVB.
Conclusions: New LBBB and RBBB are frequent intraventricular conduction distur-
bances after TAVI with a higher incidence in CoreValve prosthesis. In the majority of pts,
the LBBB persists but is not a predictor of overall and cardiovascular mortality. These
preliminary conclusions needs to be confirmed in a lorger cohort of patients.
TCT-904
Catheter Laboratory Predictors Of Post Procedure Paraprosthetic Aortic
Regurgitation Following Self-expanding Medtronic CoreValve Implantation: A
Multicentre Registry Analysis
Omar Ali1, Carl Schultz2, Andrew Jabbour1, Michael Rubens1, Mohamed Amrani1,
Carlo Di Mario1, Neil Moat1, Peter De Jaegere2, Miles Dalby1
1Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom,
2Erasmus MC, Thoraxcenter, Rotterdam, Netherlands
Background: The mechanisms of paraprosthetic aortic regurgitation (PPAR) in trans-
catheter valve intervention is related to patient and procedural factors. We studied the
association of balloon valvuloplasty and implant depth with PPAR.
Methods: We conducted a multicenter analysis of 295 patients undergoing Medtronic
CoreValve implantation with prior CT annular sizing. Significant PPAR was defined as
moderate or severe angiographic regurgitation. Implant depth was measured as the mean
distance from the nadir of the non- and left coronary sinuses to the distal valve frame
angiographically. Pre-implantation nominal and achieved balloon size during valvulo-
plasty were recorded.
Results: The majority of patients had mild (35.5%), trivial (20.7%) or no (7.6%) PPAR
with significant PPAR observed in 36% of patients. Significant PPAR was associated with
a larger mean native annular diameter (p0.01) and annulus to valve size ratio (p0.03),
Fig 1. Significant PPAR was also associated with increased depth of implantation
(p0.035). Although nominal balloon and native valve sizes were well matched,
underexpanded balloon size was associated with significant PPAR (p0.04). 13.7% of
patients had post dilatation of the implant.
Conclusions: Significant paraprosthetic aortic regurgitation following Medtronic Cor-
eValve implantation is associated with larger native valve dimensions and increased depth
of implant. Adequacy of balloon valvuloplasty may also predict PPAR.
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